Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Stopped The study was terminated voluntarily by the sponsor due to changes in clinical development strategy.
Conditions
- Head and Neck Squamous Cell Carcinoma
Interventions
Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Collaborators